What is he best known for?
The fields of study he is best known for:
- Gene
- Mutation
- Internal medicine
His primary areas of investigation include Genetics, Neurofibromatosis, Locus, Gene and Exon.
His Genetics study is mostly concerned with Neurofibromin 1, Complementary DNA, Open reading frame, Nucleic acid sequence and Amino acid.
His Neurofibromatosis study integrates concerns from other disciplines, such as Cancer research, Internal medicine and Endocrinology.
His Locus study combines topics in areas such as Camptodactyly, Knockout mouse, Hearing loss, Tall Stature and Bone growth.
His work on genomic DNA, Intron and Chromosomal translocation as part of his general Gene study is frequently connected to Diamond–Blackfan anemia, thereby bridging the divide between different branches of science.
The Exon study combines topics in areas such as Genetic heterogeneity, Point mutation and Null allele.
His most cited work include:
- The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. (1030 citations)
- A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. (937 citations)
- The neurofibromatosis type 1 gene encodes a protein related to GAP (913 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Neurofibromatosis, Genetics, Internal medicine, Pathology and Gene.
His Neurofibromatosis research is multidisciplinary, relying on both Dysplasia and Pseudarthrosis.
His research is interdisciplinary, bridging the disciplines of Molecular biology and Genetics.
His Molecular biology research is multidisciplinary, incorporating elements of Complementary DNA and Chromosome 17.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
David Viskochil combines subjects such as genomic DNA, Gene mapping and Loss of heterozygosity with his study of Locus.
He most often published in these fields:
- Neurofibromatosis (52.38%)
- Genetics (32.38%)
- Internal medicine (23.33%)
What were the highlights of his more recent work (between 2016-2021)?
- Neurofibromatosis (52.38%)
- Genetics (32.38%)
- Internal medicine (23.33%)
In recent papers he was focusing on the following fields of study:
David Viskochil spends much of his time researching Neurofibromatosis, Genetics, Internal medicine, Pediatrics and Clinical trial.
His Neurofibromatosis study is focused on Pathology in general.
David Viskochil connects Genetics with Terminal in his study.
In the field of Internal medicine, his study on Disease overlaps with subjects such as Clinical diagnosis.
His Pediatrics research is multidisciplinary, incorporating perspectives in Normal range and Proband.
His research integrates issues of Medical therapy, Surgery, MEK inhibitor and Patient participation in his study of Clinical trial.
Between 2016 and 2021, his most popular works were:
- Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. (101 citations)
- Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. (82 citations)
- Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. (51 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Mutation
- Internal medicine
His primary areas of study are Neurofibromatosis, Internal medicine, Clinical trial, Oncology and Malignant peripheral nerve sheath tumor.
David Viskochil conducted interdisciplinary study in his works that combined Neurofibromatosis and Early childhood.
His studies deal with areas such as Tolerability and Mutation as well as Internal medicine.
His work in Clinical trial addresses issues such as Surgery, which are connected to fields such as Placebo and Cohort study.
His Oncology research integrates issues from Phenotype, PI3K/AKT/mTOR pathway, Peripheral Nerve Sheath Tumors and Tuberous sclerosis.
His Malignant peripheral nerve sheath tumor research incorporates themes from Clinical endpoint, Everolimus, Combination therapy and Phases of clinical research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
